Education
About Us
Working with TipRanks
Follow Us
LIDDS AB (SE:LIDDS)
:LIDDS
Docetaxel
Solid Tumor
Phase I
Terminated
Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours
Mar 18, 2021
―
2-Hydroxyflutamide Depot
Prostate Cancer
Phase II
Completed
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer
Nov 01, 2017
―
2-Hydroxyflutamide (2-Hof)
Prostate Cancer
Phase II
Completed
A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer
Oct 17, 2014
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does LIDDS AB (LIDDS) have in its pipeline
LIDDS is currently developing the following drugs: Docetaxel, 2-Hydroxyflutamide Depot, 2-Hydroxyflutamide (2-Hof). These drug candidates are in various stages of clinical development as the company works toward FDA approval.